Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook
Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic. The company forecast 2025 sales of between $61 billion and $64 billion and earnings …